Gu-Choul Shin

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Signaling Pathway

Top Venues

Experimental & molecular medicine

Nature communications

British journal of pharmacology

The EMBO journal

This page only lists publications with an associated author ORCID identifier.

Publications

Gu-Choul Shin, Hyeong Min Lee, Nayeon Kim, Sang-Uk Seo, Kwang-Pyo Kim, Kyun-Hwan Kim
PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer. Experimental & molecular medicine 56 (1) (2024)
Gu-Choul Shin, Hyeong Min Lee, Nayeon Kim, Sang-Uk Seo, Kwang-Pyo Kim, Kyun-Hwan Kim
PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer. Experimental & molecular medicine 56 (1) (2024)
Gu-Choul Shin, Hyeong Min Lee, Nayeon Kim, Jihyeon Hur, Sang-Ku Yoo, Yun Sun Park, Hyung Soon Park, Dongryeol Ryu, Min-Ho Park, Jung Hee Park, Sang-Uk Seo, Leo Sungwong Choi, Martin Rønn Madsen, Michael Feigh, Kwang Pyo Kim, Kyun-Hwan Kim
Paraoxonase-2 agonist vutiglabridin promotes autophagy activation and mitochondrial function to alleviate non-alcoholic steatohepatitis. British journal of pharmacology (2024)
Gu-Choul Shin, Hyeong Min Lee, Nayeon Kim, Sang-Uk Seo, Kwang-Pyo Kim, Kyun-Hwan Kim
PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer. Experimental & molecular medicine 56 (1) (2024)
Gu-Choul Shin, Hyeong Min Lee, Nayeon Kim, Sang-Uk Seo, Kwang-Pyo Kim, Kyun-Hwan Kim
PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer. Experimental & molecular medicine (2024)
Gu-Choul Shin, Hyeong Min Lee, Nayeon Kim, Sang-Uk Seo, Kwang-Pyo Kim, Kyun-Hwan Kim
PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer. Experimental & molecular medicine 56 (1) (2024)
Gu-Choul Shin, Hyeong Min Lee, Nayeon Kim, Jihyeon Hur, Sang-Ku Yoo, Yun Sun Park, Hyung Soon Park, Dongryeol Ryu, Min-Ho Park, Jung Hee Park, Sang-Uk Seo, Leo Sungwong Choi, Martin Rønn Madsen, Michael Feigh, Kwang Pyo Kim, Kyun-Hwan Kim
Paraoxonase-2 agonist vutiglabridin promotes autophagy activation and mitochondrial function to alleviate non-alcoholic steatohepatitis. British journal of pharmacology 181 (19) (2024)
Gu-Choul Shin, Hyeong Min Lee, Nayeon Kim, Sang-Uk Seo, Kwang-Pyo Kim, Kyun-Hwan Kim
PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer. Experimental & molecular medicine 56 (1) (2024)
Gu-Choul Shin, Sung Ung Moon, Hong Seok Kang, Hyo-Sun Choi, Hee Dong Han, Kyun-Hwan Kim
Publisher Correction: PRKCSH contributes to tumorigenesis by selective boosting of IRE1 signaling pathway. Nature communications 10 (1) (2019)
Eun-Sook Park, Young Ho Byun, Soree Park, Yo Han Jang, Woo-Ry Han, Juhee Won, Kyung Cho Cho, Doo Hyun Kim, Ah Ram Lee, Gu-Choul Shin, Yong Kwang Park, Hong Seok Kang, Heewoo Sim, Yea Na Ha, Byeongjune Jae, Ahyun Son, Paul Kim, Jieun Yu, Hye-Min Lee, Sun-Bin Kwon, Kwang Pyo Kim, Seung-Hyun Lee, Yeong-Min Park, Baik-Lin Seong, Kyun-Hwan Kim
Co-degradation of interferon signaling factor DDX3 by PB1-F2 as a basis for high virulence of 1918 pandemic influenza. The EMBO journal 38 (10) (2019)
Gu-Choul Shin, Sung Ung Moon, Hong Seok Kang, Hyo-Sun Choi, Hee Dong Han, Kyun-Hwan Kim
PRKCSH contributes to tumorigenesis by selective boosting of IRE1 signaling pathway. Nature communications 10 (1) (2019)